RANI insider trading — Rani Therapeutics Holdings, Inc.
Over the last 90 days, insiders at Rani Therapeutics Holdings, Inc. (RANI) made 2 open-market purchases worth $50K and 2 open-market sales worth $12K, making them net buyers by $38K. The largest purchase was by Imran Talat (Chief Executive Officer), who bought 35,000 shares for $25K on Jul 17, 2026. The largest sale was by Imran Talat (Chief Executive Officer), who sold 8,014 shares for $11K on Dec 27, 2024. 2 different insiders bought shares in this period — a cluster buy, which many investors watch closely.
Updated Oct 16, 2026.
Recent RANI insider transactions
Every Form 4 filed by Rani Therapeutics Holdings, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2026 | Imran Talat | Chief Executive Officer | F · Tax withholding | Direct | 7,928 | $0.76 | $6K | Form 4 |
| Sep 27, 2026 | Javadi Alireza | Chief Technical Officer | F · Tax withholding | Direct | 309 | $0.76 | $235 | Form 4 |
| Jul 21, 2026 | Imran Mir A | Director | P · Purchase | Direct | 36,000 | $0.69 | $25K | Form 4 |
| Jun 27, 2026 | Javadi Alireza | Chief Technical Officer | F · Tax withholding | Direct | 309 | $0.74 | $229 | Form 4 |
| Mar 27, 2026 | Javadi Alireza | Chief Technical Officer | S · Sale | Direct | 386 | $0.78 | $301 | Form 4 |
| Jul 17, 2026 | Imran Talat | Chief Executive Officer | P · Purchase | Direct | 35,000 | $0.72 | $25K | Form 4 |
| Jun 27, 2026 | Imran Talat | Chief Executive Officer | F · Tax withholding | Direct | 7,927 | $0.74 | $6K | Form 4 |
| Mar 27, 2026 | Imran Talat | Chief Executive Officer | F · Tax withholding | Direct | 9,099 | $0.81 | $7K | Form 4 |
| Mar 22, 2026 | Imran Talat | Chief Executive Officer | F · Tax withholding | Direct | 8,916 | $1.13 | $10K | Form 4 |
| Dec 27, 2025 | Imran Talat | Chief Executive Officer | F · Tax withholding | Direct | 7,906 | $1.40 | $11K | Form 4 |
| Sep 27, 2025 | Imran Talat | Chief Executive Officer | F · Tax withholding | Direct | 9,077 | $0.48 | $4K | Form 4 |
| Jun 27, 2025 | Imran Talat | Chief Executive Officer | F · Tax withholding | Direct | 9,076 | $0.55 | $5K | Form 4 |
| Dec 27, 2024 | Imran Talat | Chief Executive Officer | S · Sale | Direct | 8,014 | $1.41 | $11K | Form 4 |
RANI insider trading FAQ
Are insiders buying RANI stock?
Yes. In the last 90 days, Rani Therapeutics Holdings, Inc. insiders made 2 open-market purchases totaling $50K, and 2 open-market sales totaling $12K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading RANI?
Recent buyers: Imran Mir A, Imran Talat. Recent sellers: Imran Talat, Javadi Alireza.
Where does RANI insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.